XORTX Therapeutics (XRTX) Net Income (2020 - 2026)
XORTX Therapeutics (XRTX) posted Net Income of -$808472.0 for Q1 2026, down 36.92% on a QoQ basis from -$590462.0 in Q4 2025, and down 15.72% year-over-year from -$959216.3 in Q1 2025.
XORTX Therapeutics (XRTX) Net Income (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Net Income history runs 7 years deep, the most recent figure standing at -$808472.0 for Q1 2026.
- Quarterly Net Income fell 15.72% year-over-year to -$808472.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 149.1% YoY) and the FY2025 annual result came in at -$2.7 million, down 180.17% from the prior year.
- Net Income was -$808472.0 for Q1 2026 at XORTX Therapeutics, down from -$590462.0 in the prior quarter.
- Across five years, Net Income topped out at $6.7 million in Q4 2024 and bottomed at -$3.0 million in Q1 2024.
- A 5-year average of -$702251.9 and a median of -$808472.0 in 2026 frame the typical range for Net Income.
- Annual changes were most pronounced in 2022 — Net Income tumbled 597.94% — and 2024, when it jumped 113.5%.
- XORTX Therapeutics' Net Income stood at -$2.1 million in 2022, then soared by 41.41% to -$1.3 million in 2023, then surged by 635.85% to $6.7 million in 2024, then tumbled by 108.75% to -$590462.0 in 2025, then sank by 36.92% to -$808472.0 in 2026.
- Business Quant data shows XRTX's Net Income at -$808472.0 in Q1 2026, -$590462.0 in Q4 2025, and -$649469.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | -808,472.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -808,472.00 |
| Dec 31, 2025 | -590,462.00 |
| Sep 30, 2025 | -649,469.00 |
| Jun 30, 2025 | -717,700.00 |
| Mar 31, 2025 | -698,673.00 |
| Dec 31, 2024 | 6.75 Mn |
| Sep 30, 2024 | -587,011.00 |
| Jun 30, 2024 | 170,066.00 |
| Mar 31, 2024 | -3.02 Mn |
| Jun 30, 2023 | -1.26 Mn |
| Mar 31, 2023 | -1.83 Mn |
| Dec 31, 2022 | -2.15 Mn |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -1.24 Mn |
| Mar 31, 2022 | -2.70 Mn |
| Dec 31, 2021 | 9.84 Mn |
| Sep 30, 2021 | -6.64 Mn |
| Jun 30, 2021 | -177,711.75 |
| Mar 31, 2021 | -1.72 Mn |
| Dec 31, 2020 | 1.62 Mn |